Pipradrol
Pipradrol is a central nervous system stimulant of the diphenylmethane class. Originally developed in the 1940s, it saw clinical use in the treatment of depression, fatigue, dementia, and ADHD, among other conditions. Despite demonstrating therapeutic efficacy across a range of psychiatric applications, its significant abuse potential and associated adverse effects led to its withdrawal from medical use and subsequent international scheduling beginning in the 1970s.
Contents
Dosage & Duration
Dosage
Limited empirical data; single insufflated dose of 60 mg documented as maximal experienced dose. Threshold, light, and moderate tiers remain uncharacterized for this route.
Duration
Subjective Effects
Pipradrol produces a mild, primarily cerebral stimulation rather than an intense recreational high. The experience is often described as a subtle sense of head stimulation with a faint pleasant glow and warmness, lacking any real excitement or euphoric rush even at doses well above the therapeutic range. Its stimulating action is reported to be concentrated at higher brain centers, and unlike many classical stimulants it is not followed by a post-stimulation crash. Effects are long-lasting, with wakefulness persisting for up to 12 hours when taken at higher doses or late in the day.
Physical
The body load is minimal, limited to light stimulation without significant cardiovascular or respiratory effects. Unlike amphetamine, pipradrol does not suppress appetite. Overdoses can produce nausea, abdominal pain, and, in severe cases, convulsions.
Stimulation
Stimulation is light and predominantly cerebral, with no reported effects on blood pressure or respiration and no post-stimulation crash.
Uncomfortable
Adverse physical effects are largely confined to overdose.
Cognitive
The headspace is one of mild, clear cerebral stimulation and wakefulness with a subtly pleasant, warm emotional tone. At excessive doses it can produce anxiety and insomnia, and it may worsen pre-existing anxiety or psychotic conditions.
Emotional
Enhancements
Reagent Testing
Loading reagent data
Pharmacology
Pharmacodynamics
Pipradrol acts primarily as a norepinephrine and dopamine reuptake inhibitor, blocking the reuptake of these neurotransmitters at their respective transporters. Its rewarding effects appear to be mediated in part through activation of dopamine D1 receptors. Pipradrol exhibits a preferential action on higher brain centers with relatively minimal effects on blood pressure or respiration.
Pharmacokinetics
Pipradrol is rapidly absorbed following administration, with distribution to the liver, kidneys, and brain tissue. The drug is quickly metabolized and is no longer detectable in plasma approximately 4 hours after administration. Elimination occurs through both urinary (approximately 3.5%) and fecal (approximately 5%) excretion.
Tolerance
Harm Potential
Addiction & Dependence
Psychological
ModerateRecognized abuse potential led to international regulation in the late 1970s, though it is generally considered to have lower abuse potential and milder stimulant effects compared to other stimulants in its class.
Psychosis Risk
Psychosis and hallucinations are reported very rarely. The drug is contraindicated in individuals with pre-existing psychotic states or schizophrenia as it may worsen these symptoms.
Seizure Risk
Convulsions are described as very rare and primarily associated with severe overdose cases.
History & Culture
Pipradrol was developed in the United States during the 1940s and received its patent in 1953. By the mid-1950s, it had entered the pharmaceutical market under the brand name Meratran, primarily positioned as an antidepressant. Its clinical utility expanded to include adjunct treatment for a range…
Legality
By Country
References
Source Pages
Further Reading
Automated synthesisInformation aggregated and synthesized using an autonomous workflow built by Josie Kins.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the Pipradrol article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.